Skip to main content
Journal cover image

Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19.

Publication ,  Journal Article
Subica, AM; Guerrero, EG; Martin, TKK; Okamoto, SK; Aitaoto, N; Moss, HB; Morey, BN; Wu, L-T
Published in: Drug Alcohol Rev
November 2022

INTRODUCTION: Before COVID-19, Native Hawaiians/Pacific Islanders (NH/PI) endured a heavy burden of alcohol, tobacco and other drug (ATOD) use in prior US data. Responding to reports that many NH/PI communities experienced severe COVID-19 disparities that could exacerbate their ATOD burden, we partnered with NH/PI communities to assess the substance use patterns and treatment needs of diverse NH/PIs during COVID-19. METHODS: Collaborating with NH/PI community organisations across five states with large NH/PI populations, we conducted a large-scale investigation of NH/PI ATOD use, mental health and treatment need during COVID-19. Between April and November 2021, NH/PI-heritage research staff from our community partners collected data involving 306 NH/PI adults using several community-based recruitment methods (e-mail, telephone, in-person) and two survey approaches: online and paper-and-pencil. Multivariate regressions were conducted to examine potential predictors of NH/PI alcohol use disorder and need for behavioural health treatment. RESULTS: During COVID-19, 47% and 22% of NH/PI adults reported current alcohol and cigarette use, while 35% reported lifetime illicit substance use (e.g., cannabis, opioid). Depression and anxiety were high, and alcohol use disorder, major depression and generalised anxiety disorder prevalence were 27%, 27% and 19%, respectively. One-third of participants reported past-year treatment need with lifetime illicit substance use, COVID-19 distress and major depression respectively associating with 3.0, 1.2, and 5.3 times greater adjusted odds for needing treatment. CONCLUSIONS: NH/PI adults reported heavy ATOD use, depression, anxiety and treatment need during COVID-19. Targeted research and treatment services may be warranted to mitigate COVID-19's negative behavioural health impact on NH/PI communities.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Drug Alcohol Rev

DOI

EISSN

1465-3362

Publication Date

November 2022

Volume

41

Issue

7

Start / End Page

1653 / 1663

Location

Australia

Related Subject Headings

  • United States
  • Tobacco Products
  • Substance-Related Disorders
  • Substance Abuse
  • Prevalence
  • Nicotiana
  • Native Hawaiian or Other Pacific Islander
  • Mental Health
  • Humans
  • Hawaii
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Subica, A. M., Guerrero, E. G., Martin, T. K. K., Okamoto, S. K., Aitaoto, N., Moss, H. B., … Wu, L.-T. (2022). Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19. Drug Alcohol Rev, 41(7), 1653–1663. https://doi.org/10.1111/dar.13522
Subica, Andrew M., Erick G. Guerrero, Tammy K. K. Martin, Scott K. Okamoto, Nia Aitaoto, Howard B. Moss, Brittany N. Morey, and Li-Tzy Wu. “Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19.Drug Alcohol Rev 41, no. 7 (November 2022): 1653–63. https://doi.org/10.1111/dar.13522.
Subica AM, Guerrero EG, Martin TKK, Okamoto SK, Aitaoto N, Moss HB, et al. Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19. Drug Alcohol Rev. 2022 Nov;41(7):1653–63.
Subica, Andrew M., et al. “Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19.Drug Alcohol Rev, vol. 41, no. 7, Nov. 2022, pp. 1653–63. Pubmed, doi:10.1111/dar.13522.
Subica AM, Guerrero EG, Martin TKK, Okamoto SK, Aitaoto N, Moss HB, Morey BN, Wu L-T. Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19. Drug Alcohol Rev. 2022 Nov;41(7):1653–1663.
Journal cover image

Published In

Drug Alcohol Rev

DOI

EISSN

1465-3362

Publication Date

November 2022

Volume

41

Issue

7

Start / End Page

1653 / 1663

Location

Australia

Related Subject Headings

  • United States
  • Tobacco Products
  • Substance-Related Disorders
  • Substance Abuse
  • Prevalence
  • Nicotiana
  • Native Hawaiian or Other Pacific Islander
  • Mental Health
  • Humans
  • Hawaii